MedWatch

Rhovac wants to raise more than a million dollars on the stock exchange

The listed Danish company Rhovac issues new shares for up to USD 3 million, which will finance new research activities as well as speed up the company's search for a potential buyer for its cancer vaccine.

Photo: /ritzau Scanpix/Jens Panduro

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Regeringen og Novo Nordisk giver 50 mio til sygdomsbekæmpelse i fattige lande

Et FN-partnerskab, der skal være med til at bekæmpe ikke-smitsomme sygdomme såsom diabetes i lav- og mellemindkomstlande, får nu godt 50 mio. kr. i støtte fra den danske regering og medicinalselskabet Novo Nordisk, som ifølge topchef Lars Fruergaard Jørgensen aner "en mere vedvarende forretning" i disse lande på sigt.

Related articles